Medical Condition News

RSS

Compugen discovers CGEN-15001 protein for treatment of autoimmune disorders

Compugen Ltd. announced today the discovery and experimental validation of CGEN-15001 for the treatment of autoimmune disorders.

2 Feb 2010

Xiaflex receives FDA approval for treatment of Dupuytren's contracture

The U.S. Food and Drug Administration today approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person's ability to straighten and properly use their fingers.

2 Feb 2010

FDA approves Taro Pharmaceutical Industries' levetiracetam tablets ANDA

Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration (“FDA”) for its Abbreviated New Drug Application (“ANDA”) for Levetiracetam Tablets, 250 mg, 500 mg, 750 mg and 1000 mg (“levetiracetam tablets”).

2 Feb 2010

Persons with impaired hearing should be encouraged by family members to seek appropriate treatment

Recent data arising out of the Better Hearing Institute's "MarkeTrak" national study demonstrates that hearing loss is prevalent, serious, and often denied by the sufferer. The information revealed suggests that family members of the hearing impaired should actively encourage their loved ones to address their hearing problem, an effort which will greatly benefit both the hard of hearing and their kin.

2 Feb 2010

CTS: More people are being admitted to Canadian hospitals each year with COPD

A review of Canadian data by the nation's leading lung specialists has provided the factual evidence to support what respirologists across the country have been suspecting for some time. Shockingly, more people are being admitted to Canadian hospitals each year with chronic obstructive pulmonary disease (COPD) than any other major chronic illness (including heart attacks) and that number has been increasing dramatically in recent years.

2 Feb 2010

BC Cancer Foundation's campaign passes significant threshold with major donation for cancer care

Join the BC Cancer Foundation and community leaders for an exciting announcement which will significantly impact the lives of cancer patients and their families throughout Vancouver Island, the Gulf Islands and beyond.

2 Feb 2010

Vantia Therapeutics initiates Phase IIb trial of VA106483 for nocturia

Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, today announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia.

2 Feb 2010

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on ALL

Treating acute lymphocytic leukemia (ALL) can bring many challenges, particularly in the adult population. To optimally manage this disease in adult patients, healthcare professionals must understand and identify characteristics of high-risk disease, utilize best strategies for preventing central nervous system relapse, and recognize the important role of post-remission hematopoietic stem cell transplantation in ALL therapy.

2 Feb 2010

FDA requests additional data on CMC section of NDA for taliglucerase alfa from Protalix BioTherapeutics

Protalix BioTherapeutics, Inc. announced today that, in connection with the New Drug Application (NDA) filed by the Company in December 2009 for taliglucerase alfa for the treatment of Gaucher disease, the U.S. Food and Drug Administration (FDA) has requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.

2 Feb 2010

Health and environmental groups propose new ozone standard to help reduce asthma attacks and premature deaths

The American Lung Association, Breathe California, Coalition for Clean Air, Environmental Defense Fund and the Sierra Club will hold a joint press conference in support of the U.S. Environmental Protection Agency (EPA) proposal to strengthen the national limits for ozone "smog" pollution. The organizations are calling on the EPA to enact the most protective ozone standard under consideration to protect the health of our communities and the environment from serious harm.

2 Feb 2010

Researchers explore how brain circuitry and learning changes over time

New research shows our brains are a lot more chaotic than previously thought, and that this might be a good thing. Neurobiologists at the University of Maryland have discovered information about how the brain processes sound that challenges previous understandings of the auditory cortex, which had suggested an organization based on precise neuronal maps.

2 Feb 2010

Simulation training may help improve driving skills of Parkinson's disease patients

In a first-of-its-kind study, Medical College of Georgia researchers are testing whether simulation driving can reduce Parkinson's patients' threefold increased risk of car accidents.

2 Feb 2010

New approach may help in fighting Cerebral Palsy

On average, a child is diagnosed with Cerebral Palsy every hour of every day in the United States. It's a disease that can affect everything from a child's vision to their ability to walk. Therapy for these kids is tough and frustrating as this is a chronic health condition.

2 Feb 2010

Study compares common treatment options for infants born with clubfoot

Clubfoot affects one in a thousand babies born in the United States, but with proper corrective treatment and follow-up, infants born with clubfoot can have feet compatible with an active, normal lifestyle. A new study in the February 2010 issue of the Journal of Bone and Joint Surgery (JBJS) compared two common treatment options for clubfoot - Ponseti method and surgical treatment.

2 Feb 2010

Campbell government cuts EIBI program for ASD children

On Friday, B.C.'s last centre offering intensive autism treatment for children under 6 closed its doors. The provincial government had cancelled all funding, eliminated 42 jobs and cut adrift all the children currently being treated and all those on the waiting list.

2 Feb 2010

Scientists find that protease HtrA2 can "clean" cells of oncogene WT1

Dr Jorg Hartkamp and Dr Stefan Roberts have found that the protease HtrA2 can "clean" cells of the oncogene WT1, which is found at high levels in many leukaemias and solid cancers such as breast and lung cancer.

From The University of Manchester 2 Feb 2010

Self-directed learning program may benefit parents with autistic children

Through the use of instructional DVDs, parents of children with autism can learn how to teach their child to communicate and improve their behavior, according to research published in the January 2010 issue of The Journal of Positive Behavior Interventions (published by the Hammill Institute on Disabilities and SAGE).

2 Feb 2010

Strength of distal leg musculature contributes to SCK difficulty in older adults

Decreased muscle strength is associated with difficulty in performing functional activities such as stooping, crouching, or kneeling (SCK) in older adults, according to an observational study published in the January issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA). These researchers found that adults with SCK difficulty had significant decreases in adjusted strength measurements of trunk extensor, knee extensor, and ankle flexion muscles.

2 Feb 2010

Study may yield potential treatments for brain damage and neurodegenerative diseases

Scientists at the Swedish medical university Karolinska Institutet have shown how transplanted stem cells can connect with and rescue threatened neurons and brain tissue. The results point the way to new possible treatments for brain damage and neurodegenerative diseases.

2 Feb 2010

Unusual molecule in brain and retina can trigger vision loss

Scientists have identified a double agent in the eye that, once triggered, can morph from neuron protector to neuron killer. The discovery has significant health implications since the neurons killed through this process results in vision loss and blindness.

2 Feb 2010

Medical Condition News

Compugen discovers CGEN-15001 protein for treatment of autoimmune disorders

Xiaflex receives FDA approval for treatment of Dupuytren's contracture

FDA approves Taro Pharmaceutical Industries' levetiracetam tablets ANDA

Persons with impaired hearing should be encouraged by family members to seek appropriate treatment

CTS: More people are being admitted to Canadian hospitals each year with COPD

BC Cancer Foundation's campaign passes significant threshold with major donation for cancer care

Vantia Therapeutics initiates Phase IIb trial of VA106483 for nocturia

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on ALL

FDA requests additional data on CMC section of NDA for taliglucerase alfa from Protalix BioTherapeutics

Health and environmental groups propose new ozone standard to help reduce asthma attacks and premature deaths

Researchers explore how brain circuitry and learning changes over time

Simulation training may help improve driving skills of Parkinson's disease patients

New approach may help in fighting Cerebral Palsy

Study compares common treatment options for infants born with clubfoot

Campbell government cuts EIBI program for ASD children

Scientists find that protease HtrA2 can "clean" cells of oncogene WT1

Self-directed learning program may benefit parents with autistic children

Strength of distal leg musculature contributes to SCK difficulty in older adults

Study may yield potential treatments for brain damage and neurodegenerative diseases

Unusual molecule in brain and retina can trigger vision loss

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News